NCT02784860View on ClinicalTrials.gov

Effects of Intravenous Lidocaine During Sedation for Colonoscopy.

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

September 30, 2016

Study Completion Date

October 31, 2016

Conditions
Colonoscopy
Interventions
DRUG

Lidocaine

Propofol (0.5 mg/kg or more) is titrated to provide loss of consciousness. Then in the lidocaine group, lidocaine 2% is administered as a bolus followed by a continuous intravenous infusion after loss of consciousness

DRUG

normal saline

Propofol (0.5 mg/kg or more) is titrated to provide loss of consciousness. Then in the placebo group, the same volume of normal saline is administered after loss of consciousness

Trial Locations (1)

4000

University Hospital of Liege, Liège

All Listed Sponsors
lead

University of Liege

OTHER

NCT02784860 - Effects of Intravenous Lidocaine During Sedation for Colonoscopy. | Biotech Hunter | Biotech Hunter